| Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012 | 2086 | 2012 |
| Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion MH Barnett, JW Prineas Annals of Neurology 55 (4), 458-468, 2004 | 1526 | 2004 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 1027 | 2018 |
| Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis CG Bien, A Vincent, MH Barnett, AJ Becker, M Blümcke, F Graus Brain, 2012 | 653 | 2012 |
| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018 | 543 | 2018 |
| Immunopathology of secondary‐progressive multiple sclerosis JW Prineas, EE Kwon, ES Cho, LR Sharer, MH Barnett, EL Oleszak, ... Annals of neurology 50 (5), 646-657, 2001 | 537 | 2001 |
| Multiple sclerosis: distribution of inflammatory cells in newly forming lesions APD Henderson, MH Barnett, JDE Parratt, JW Prineas Annals of neurology 66 (6), 739-753, 2009 | 528 | 2009 |
| Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (9), 973-985, 2015 | 469 | 2015 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 434 | 2016 |
| The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis V Devonshire, Y Lapierre, R Macdonell, C Ramo‐Tello, F Patti, ... European journal of neurology 18 (1), 69-77, 2010 | 422 | 2010 |
| The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects A Minagar, MH Barnett, RHB Benedict, D Pelletier, I Pirko, MA Sahraian, ... Neurology 80 (2), 210-219, 2013 | 392 | 2013 |
| Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis S Ramanathan, K Prelog, EH Barnes, EM Tantsis, SW Reddel, ... Multiple Sclerosis Journal 22 (4), 470-482, 2016 | 366 | 2016 |
| The evidence for a role of B cells in multiple sclerosis G Disanto, JM Morahan, MH Barnett, G Giovannoni, SV Ramagopalan Neurology 78 (11), 823-832, 2012 | 312 | 2012 |
| Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ... Neuroimmunology & Neuroinflammation 1 (4), e40, 2014 | 247 | 2014 |
| Exosomal microRNA signatures in multiple sclerosis reflect disease status S Ebrahimkhani, F Vafaee, PE Young, SSJ Hur, S Hawke, E Devenney, ... Scientific reports 7 (1), 14293, 2017 | 246 | 2017 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 218 | 2015 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 218 | 2014 |
| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 209 | 2013 |
| Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ... PloS one 10 (6), e0122686, 2015 | 203 | 2015 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015 | 191 | 2015 |
Chenyu WangBrain and Mind Centre, University of Sydney; Sydney Neuroimaging Analysis CentreVerified email at sydney.edu.au
